Related Experiment Videos
Introduction to the development of paroxetine, a novel antidepressant
Acta Psychiatrica Scandinavica. Supplementum
|January 1, 1989
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A water lick conflict paradigm using drug experienced rats.
Psychopharmacology·1981
Inhibition of apomorphine-induced climbing in mice by cholinergic drugs and neuroleptics.
Acta pharmacologica et toxicologica·1979
Inhibition of apomorphine-induced hypermotility in rats by chlorpromazine, perphenazine, thioridazine and melperone.
Acta pharmacologica et toxicologica·1977
Inhibition and potentiation of apomorphine-induced hypermotility in rats by neuroleptics.
European journal of pharmacology·1976
Use of psychotropic drugs during pregnancy and breast-feeding.
Acta psychiatrica Scandinavica. Supplementum·2015
Getting depression clinical practice guidelines right: time for change?
Acta psychiatrica Scandinavica. Supplementum·2013
Manipulating melatonin in managing mood.
Acta psychiatrica Scandinavica. Supplementum·2013
Chronobiology of mood disorders.
Acta psychiatrica Scandinavica. Supplementum·2013
Lifestyle management of unipolar depression.
Acta psychiatrica Scandinavica. Supplementum·2013
Psychological management of unipolar depression.
Acta psychiatrica Scandinavica. Supplementum·2013
Participant and physician perspectives on the use of SGLT2 inhibitors in type 1 diabetes.
Diabetic medicine : a journal of the British Diabetic Association·2026
Pharmacological Principles in the Use and Development of Antituberculosis Drugs.
Cold Spring Harbor perspectives in medicine·2026
[177Lu] Lu-PSMA-I&T for prostate cancer radioligand therapy: A radiopharmacy's journey from synthesis to cost-effectiveness.
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine·2026
The widening medication adherence gap.
PLoS medicine·2026
Hematological neoplasms after PRRT: experience from long term follow-up of 173 patients in a tertiary center.
Endocrine oncology (Bristol, England)·2026